EAU Updates Guidance for PSMA-PET Imaging
MELBOURNE, Australia and LIÈGE, Belgium, March 21, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the updated 2022 ‘Guidelines on Prostate…
Browsing Tag
Australian Stock Exchange:TLX.AX
ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the “Company”) today announces that ZIRCON (Zirconium in Renal Cancer Oncology,…
Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply…
MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a global clinical supply agreement with…
Japanese Prostate Cancer Imaging Trial Meets Study Objectives
MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) in collaboration with Kanazawa University today…
First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
MELBOURNE, Australia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s…
Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer…
MELBOURNE, Australia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a clinical data access…
First Patient Dosed in Study of Targeted Alpha Therapy Candidate for Bladder Cancer
MELBOURNE, Australia and NANTES, France, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Nantes-based ATONCO S.A.S. (‘ATONCO’) today…
FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®
MELBOURNE, Australia and INDIANAPOLIS, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the…
Illuccix® recebe autorização de uso de imagens de câncer de próstata no Brasil
MELBOURNE, Austrália e PORTO ALEGRE, Brasil, Nov. 30, 2021 (GLOBE NEWSWIRE) -- A Telix Pharmaceuticals Limited (ASX: TLX, Telix, a Empresa) anunciou hoje que a Agência Nacional de…
Illuccix® Granted Use Authorisation for Prostate Cancer Imaging in Brazil
MELBOURNE, Australia and PORTO ALEGRE, Brazil, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Brazilian Health…